FAQ

A collaborative platform where ESGO-accredited centres share real-world clinical data in gynaecological oncology, validate quality indicators, assess guideline adherence, and generate evidence to improve patient care.

Each centre can only access the data it has entered itself. All data is pseudonymised, so only the individuals who originally entered a record can identify the corresponding patient. During research, raw data is handled exclusively by the ESGO statistical team. ESGO takes GDPR compliance and data protection extremely seriously at every stage of the process.

The ovarian cancer database is currently live and collecting data. An endometrial cancer database is under development, and a cervical cancer database is in the pipeline. We're excited about this progress and the range of studies it will enable across gynaecological oncology.

Any ESGO-accredited centre (no matter the accreditation type) can apply by contacting us at database@www.esgo.org. Participation involves signing the framework agreement followed by data submission.

Centres are encouraged to enter data on their eligible patients and can then decide which specific studies they'd like to participate in using that data. Submission is done via REDCap, with data submission instructions available to guide the process. Centres may occasionally receive data queries to help ensure completeness.

By joining, your centre becomes part of one of the largest gynaecological oncology real-world data databases in the world — putting you at the forefront of international research and giving your team real visibility and prestige within the field. You can propose your own research projects and receive a scientific grant to lead them. Every publication that comes out of the database includes authorship for the centres that contributed data, so your work is formally recognised. You'll also have a direct hand in shaping the future standards of care and improving outcomes for women with gynaecological cancers across Europe and beyond. And as a practical bonus: data you've entered can be used toward ESGO re-accreditation, at a 50% reduced fee.

No. Centres need to hold a relevant ESGO accreditation, for which a separate administrative fee applies. But there is no separate participation fee for joining the ESGO Database Consortium or contributing data.

Contributing data does require time and effort from participating centres, but a single dataset can support multiple research projects and publications, allowing centres to gain continued scientific value from their contribution.

Each ESGO Database study follows an established ethical and data-protection framework, and participating centres obtain local Ethics Committee or Institutional Review Board approval as required.

The ESGO Database collects data for secondary use, meaning information that has already been collected by the centre as part of routine patient care. Any potential requirements regarding patient consent are handled in accordance with the applicable study design and local regulations.

ESGO Quality Indicators define measurable standards for high-quality gynaecological cancer care. The ESGO Database provides the real-world data needed to assess how these indicators perform across different centres and patient populations.

This helps ESGO validate existing indicators, identify areas for improvement and support the development of future quality standards.

Yes. Any ESGO-accredited centre is very welcome to join, regardless of geographical location or accreditation type.

International participation strengthens the ESGO Database by bringing together experience from different healthcare systems, clinical practices and patient populations, making the resulting evidence more robust and widely relevant.